199 related articles for article (PubMed ID: 9563368)
21. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
Holliday SM; Faulds D; Sorkin EM
Drugs; 1994 Feb; 47(2):318-31. PubMed ID: 7512904
[TBL] [Abstract][Full Text] [Related]
22. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
Derendorf H; Meltzer EO
Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
[TBL] [Abstract][Full Text] [Related]
23. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids.
Smith CL; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):956-60. PubMed ID: 9793625
[TBL] [Abstract][Full Text] [Related]
24. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
Ohbayashi H; Yamase H
Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
Kaliner MA
Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
[TBL] [Abstract][Full Text] [Related]
26. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
Lumry WR
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW; Wisniewski A; Honour J; Tattersfield AE
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate.
Phillipps GH
Respir Med; 1990 Nov; 84 Suppl A():19-23. PubMed ID: 2287791
[TBL] [Abstract][Full Text] [Related]
30. Relative safety and efficacy of inhaled corticosteroids.
Barnes N
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S460-4. PubMed ID: 9563373
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids.
Atsuta J; Plitt J; Bochner BS; Schleimer RP
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):643-50. PubMed ID: 10100995
[TBL] [Abstract][Full Text] [Related]
32. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ; Grove A; Cargill RI; Lipworth BJ
Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
[TBL] [Abstract][Full Text] [Related]
33. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein.
Powell N; Till SJ; Kay AB; Corrigan CJ
Clin Exp Allergy; 2001 Jan; 31(1):69-76. PubMed ID: 11167953
[TBL] [Abstract][Full Text] [Related]
34. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate.
Valotis A; Högger P
Respir Res; 2007 Jul; 8(1):54. PubMed ID: 17650349
[TBL] [Abstract][Full Text] [Related]
35. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ; Lipworth BJ
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[TBL] [Abstract][Full Text] [Related]
36. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ
J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
[TBL] [Abstract][Full Text] [Related]
37. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ; Clark DJ; McFarlane LC
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[TBL] [Abstract][Full Text] [Related]
38. Adrenal function and high dose inhaled corticosteroids for asthma.
Yiallouros PK; Milner AD; Conway E; Honour JW
Arch Dis Child; 1997 May; 76(5):405-10. PubMed ID: 9196354
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A; Hall I; Spelman R
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[TBL] [Abstract][Full Text] [Related]
40. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
Wilson AM; Lipworth BJ
Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
